Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (DE:CVS)
XETRA:CVS
CVS Health (CVS) Stock Forecast & Price Target
22 Followers
See the Price Targets and Ratings of:
CVS Analyst Ratings
Moderate Buy
10 Buy
9 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CVS Stock 12 Month Forecast
Average Price Target
€61.93
▲(18.96% Upside)
| Highest Price Target€79.24 | Average Price Target€61.93 | Lowest Price Target€53.44 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Mizuho Securities
Reiterated
06/17/24
Cantor Fitzgerald
Reiterated
06/12/24
Leerink Partners
Reiterated
06/04/24
Robert W. Baird
Initiated
05/29/24
Bank of America Securities
Reiterated
05/14/24
Truist Financial
Reiterated
05/08/24
Argus Research
Reiterated
05/08/24
TD Cowen
€91.21→€54.36
Hold
4.42%
Upside
Downgraded
05/07/24
CVS Health downgraded to Hold from Buy at TD CowenCVS Health downgraded to Hold from Buy at TD Cowen
Oppenheimer
―
Hold
―
Reiterated
05/02/24
CVS Health (CVS) Receives a Rating Update from a Top Analyst
Morgan Stanley
€78.31→€59.89
Buy
15.04%
Upside
Reiterated
05/02/24
CVS Health (CVS) PT Lowered to $65 at Morgan StanleyMorgan Stanley analyst Erin Wright lowered the price target on CVS Health (NYSE: CVS) to $65.00 (from $85.00) while maintaining a Overweight rating.
Raymond James
€78.31→€59.89
Buy
15.04%
Upside
Reiterated
05/02/24
CVS Health price target lowered to $65 from $85 at Raymond JamesCVS Health price target lowered to $65 from $85 at Raymond James
RBC Capital
€77.39→€62.65
Buy
20.35%
Upside
Reiterated
05/02/24
RBC Capital Remains a Buy on CVS Health (CVS)
Best Analysts Covering CVS Health
Which Analyst Should I Follow If I Want to Buy DE:CVS and Sell After:
1 Month
3 Months
1 Year
Success Rate
15/28 ratings generated profit
Average Return
+4.09%
reiterated a buy rating 2 months ago
Copying John Ransom's trades and holding each position for 1 Year would result in 53.57% of your transactions generating a profit, with an average return of +4.09% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CVS Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
0
0
0
1
1
Buy
30
19
20
19
19
Hold
8
9
8
17
18
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
28
28
37
38
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
CVS Financial Forecast
CVS Stock Forecast FAQ
What is DE:CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is €61.93.
What is DE:CVS’s upside potential, based on the analysts’ average price target?
CVS Health Corp has 18.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Health Corp a Buy, Sell or Hold?
CVS Health Corp has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 9 hold ratings and 0 sell ratings.
What is CVS Health Corp’s share price target?
The average share price target for CVS Health Corp is €61.93. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €79.24 ,and the lowest forecast is €53.44. The average share price target represents 18.96% Increase from the current price of €52.06.
The highest analyst share price target is €79.24 ,and the lowest forecast is €53.44. The average share price target represents 18.96% Increase from the current price of €52.06.
What do analysts say about CVS Health Corp?
CVS Health Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of CVS Health Corp?
To buy shares of DE:CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.